Prof. Victor D. Rosenthal, MD, PhD, is a specialist in Internal Medicine and infectious diseases with an Infection Prevention fellowship at Wisconsin University and a certification in Clinical Effectiveness from Harvard University. He is a Professor in the Public Health Department at the University of Miami.

Since 2002, he has been the Founder and Chief Scientific Officer of the International Nosocomial Infection Control Consortium (INICC), which researches the surveillance and prevention of central line-associated bloodstream infections (CLABSIs) in 45 countries in Latin America, Asia, Africa, the Middle East, and Eastern Europe. In this setting, he has led over 2,500 researchers. Over the last 30 years, he has been a keynote speaker at thousands of events in 900 cities in 71 countries.

He has 421 scientific publications, which have been cited in over 28,500 peer-reviewed papers. His H index is 72. He serves on the editorial boards of the American Journal of Infection Control (AJIC) and other journals, reviews over 100 peer-reviewed journals, including The Lancet, and has received 10 international awards for his research, including those of APIC and the Society for Healthcare Epidemiology of America (SHEA).

He has collaborated as an editor-in-chief or reviewer of standards for several scientific organizations, including the Infusion Nurses Society (INS), International Society of Infectious Diseases (ISID), Association for Vascular Access (AVA), Joint Commission International (JCI), World Health Organization (WHO), and the governments of Hong Kong, Taiwan, Colombia, Brazil, and Argentina. He is the Editor-in-Chief and Committee Member of the INS Infusion Therapy Standards of Practice, to be published in 2027, and the editor-in-chief of the 2024 ISID Guidelines to Prevent CLABSI.